A Randomized Trial of Closed-Loop Control in Children with Type 1 Diabetes.

Marc D BretonLauren G KanapkaRoy W BeckLaya EkhlaspourGregory P ForlenzaEda CengizMelissa SchoelwerKatrina J RuedyEmily JostLori CarriaEmma EmoryLiana J HsuMary OliveriCraig C KollmanBetsy B DokkenStuart A WeinzimerMark D DeBoerBruce A BuckinghamDaniel CherñavvskyR Paul Wadwanull null

Published in: The New England journal of medicine (2020)

In this 16-week trial involving children with type 1 diabetes, the glucose level was in the target range for a greater percentage of time with the use of a closed-loop system than with the use of a sensor-augmented insulin pump. (Funded by Tandem Diabetes Care and the National Institute of Diabetes and Digestive and Kidney Diseases; ClinicalTrials.gov number, NCT03844789.).

Keyphrases

type diabetes
young adults
glycemic control
cardiovascular disease
clinical trial
study protocol
blood glucose
randomized controlled trial
phase iii
metabolic syndrome
phase ii
placebo controlled